You just read:

Infinity Pharmaceuticals and Bristol-Myers Squibb Expand Clinical Collaboration Evaluating IPI-549 in Combination with Opdivo (Nivolumab)

News provided by

Infinity Pharmaceuticals, Inc.

Sep 25, 2017, 08:02 ET